Since the mid-1970s Vetter has been producing aseptically prefilled drug delivery systems – among them primarily standard syringe systems, cartridge systems, vials and self-patented application systems such as the Vetter dual-chamber systems. All processes and products are tested in compliance with international cGMP standards. To date, the number of client products with FDA approval exceeds 25. Our production employs the comprehensive spectrum of modern aseptic technology, for example Restricted Access Barrier Systems (RABS). As specialists in handling of sensitive “high-value” drugs we have extensive experience in commercial production and final packaging of biotechnologically derived drugs and aseptic suspensions.
